Board of Directors

Appointed to the Board of IHH Healthcare Berhad (IHH) in February 2023, Mr Tomo Nagahiro was an alternate director to Mr Takeshi Akutsu on the Board of IHH, a role he assumed in April 2022 until January 2023. He was also the alternate director to Mr Masato Sugahara and Mr Koji Nagatomi during their tenure as Directors of IHH between April 2019 and March 2022.

Mr Nagahiro has been the General Manager of Strategic Planning Department in Wellness Business Unit of Mitsui & Co., Ltd (Mitsui), overseeing Mitsui’s investment in IHH since April 2019.

Mr Nagahiro has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. Preceding his current appointment, he was seconded to MIMS Pte Ltd which is based in Singapore as the Chief Operating Officer from 2015 to 2018.

Prior to this, Mr Nagahiro was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015.

Academic/Professional Qualification(s)

• Bachelor of Arts in Law, University of Tokyo, Japan
• Master of Business Administration, Kellogg School of Management, Northwestern University
• U.S. Certified Public Accountant

Present Directorship(s)

• Nil

Notes

• Does not have any family relationships with any directors and / or major shareholders of the Company.
• Does not have any conflict of interest with the Company.
• Does not have any convictions for offences within the past five years other than for traffic offences, if any.